Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer

Clinical trial NCT01575522 · COMPLETED

Trial details

NCT number: NCT01575522
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IV Breast Cancer Triple-Negative Breast Carcinoma

Start date: 2012-03-01
Primary completion: 2013-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.